Synthesis of a New Zinc-Mixed Ligand Complex and Evaluation of Its Antidiabetic Properties in High Fat Diet: Low Dose Streptozotocin Induced Diabetic Rats

Due to the multifactorial and multisystemic nature of diabetes mellitus, it is often treated with a combination of therapeutic agents having different mode of action. Earlier, we have synthesized several organozinc complexes and evaluated their safety and antidiabetic properties in experimental type...

Full description

Bibliographic Details
Main Authors: Muruganantham Koothappan, Roshana Devi Vellai, Iyyam Pillai Subramanian, Sorimuthu Pillai Subramanian
Format: Article
Language:English
Published: Korean Diabetes Association 2018-04-01
Series:Diabetes & Metabolism Journal
Subjects:
Online Access:https://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-42-244.pdf
_version_ 1828399970699444224
author Muruganantham Koothappan
Roshana Devi Vellai
Iyyam Pillai Subramanian
Sorimuthu Pillai Subramanian
author_facet Muruganantham Koothappan
Roshana Devi Vellai
Iyyam Pillai Subramanian
Sorimuthu Pillai Subramanian
author_sort Muruganantham Koothappan
collection DOAJ
description Due to the multifactorial and multisystemic nature of diabetes mellitus, it is often treated with a combination of therapeutic agents having different mode of action. Earlier, we have synthesized several organozinc complexes and evaluated their safety and antidiabetic properties in experimental type 2 diabetes mellitus (T2DM). More recently, we have synthesized a metformin-3-hydroxyflavone complex and studied its antidiabetic efficacy in experimental rats. In the present study, a new zinc-mixed ligand (metformin-3-hydroxyflavone) was synthesized, characterized by spectral studies and its antidiabetic properties was evaluated in HFD fed—low dose streptozotocin induced T2DM in rats. The hypoglycemic efficacy of the complex was evaluated through oral glucose tolerance test, homeostasis model assessment of insulin resistance, quantitative insulin sensitivity check index and by determining the status of important biochemical parameters. Oral administration of the complex at a concentration of 10 mg/kg body weight/rat/day for 30 days significantly improved the glucose homeostasis. The complex possesses significant antidiabetic properties relatively at a less concentration than metformin-3-hydroxyflavone complex in ameliorating hyperglycemia.
first_indexed 2024-12-10T09:24:30Z
format Article
id doaj.art-102af5de73854ff083260ca68c2903c1
institution Directory Open Access Journal
issn 2233-6079
2233-6087
language English
last_indexed 2024-12-10T09:24:30Z
publishDate 2018-04-01
publisher Korean Diabetes Association
record_format Article
series Diabetes & Metabolism Journal
spelling doaj.art-102af5de73854ff083260ca68c2903c12022-12-22T01:54:34ZengKorean Diabetes AssociationDiabetes & Metabolism Journal2233-60792233-60872018-04-0142324424810.4093/dmj.2018.0002Synthesis of a New Zinc-Mixed Ligand Complex and Evaluation of Its Antidiabetic Properties in High Fat Diet: Low Dose Streptozotocin Induced Diabetic RatsMuruganantham Koothappan0Roshana Devi Vellai1Iyyam Pillai Subramanian2Sorimuthu Pillai Subramanian3Department of Biochemistry, University of Madras, Guindy Campus, Chennai, .IndiaDepartment of Biochemistry, University of Madras, Guindy Campus, Chennai, .IndiaPG and Research Department of Chemistry, Pachaiyappa's College, Chennai, .IndiaDepartment of Biochemistry, University of Madras, Guindy Campus, Chennai, .IndiaDue to the multifactorial and multisystemic nature of diabetes mellitus, it is often treated with a combination of therapeutic agents having different mode of action. Earlier, we have synthesized several organozinc complexes and evaluated their safety and antidiabetic properties in experimental type 2 diabetes mellitus (T2DM). More recently, we have synthesized a metformin-3-hydroxyflavone complex and studied its antidiabetic efficacy in experimental rats. In the present study, a new zinc-mixed ligand (metformin-3-hydroxyflavone) was synthesized, characterized by spectral studies and its antidiabetic properties was evaluated in HFD fed—low dose streptozotocin induced T2DM in rats. The hypoglycemic efficacy of the complex was evaluated through oral glucose tolerance test, homeostasis model assessment of insulin resistance, quantitative insulin sensitivity check index and by determining the status of important biochemical parameters. Oral administration of the complex at a concentration of 10 mg/kg body weight/rat/day for 30 days significantly improved the glucose homeostasis. The complex possesses significant antidiabetic properties relatively at a less concentration than metformin-3-hydroxyflavone complex in ameliorating hyperglycemia.https://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-42-244.pdfDiabetes mellitus, type 2Hypoglycemic agentsMetforminRatsZinc
spellingShingle Muruganantham Koothappan
Roshana Devi Vellai
Iyyam Pillai Subramanian
Sorimuthu Pillai Subramanian
Synthesis of a New Zinc-Mixed Ligand Complex and Evaluation of Its Antidiabetic Properties in High Fat Diet: Low Dose Streptozotocin Induced Diabetic Rats
Diabetes & Metabolism Journal
Diabetes mellitus, type 2
Hypoglycemic agents
Metformin
Rats
Zinc
title Synthesis of a New Zinc-Mixed Ligand Complex and Evaluation of Its Antidiabetic Properties in High Fat Diet: Low Dose Streptozotocin Induced Diabetic Rats
title_full Synthesis of a New Zinc-Mixed Ligand Complex and Evaluation of Its Antidiabetic Properties in High Fat Diet: Low Dose Streptozotocin Induced Diabetic Rats
title_fullStr Synthesis of a New Zinc-Mixed Ligand Complex and Evaluation of Its Antidiabetic Properties in High Fat Diet: Low Dose Streptozotocin Induced Diabetic Rats
title_full_unstemmed Synthesis of a New Zinc-Mixed Ligand Complex and Evaluation of Its Antidiabetic Properties in High Fat Diet: Low Dose Streptozotocin Induced Diabetic Rats
title_short Synthesis of a New Zinc-Mixed Ligand Complex and Evaluation of Its Antidiabetic Properties in High Fat Diet: Low Dose Streptozotocin Induced Diabetic Rats
title_sort synthesis of a new zinc mixed ligand complex and evaluation of its antidiabetic properties in high fat diet low dose streptozotocin induced diabetic rats
topic Diabetes mellitus, type 2
Hypoglycemic agents
Metformin
Rats
Zinc
url https://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-42-244.pdf
work_keys_str_mv AT murugananthamkoothappan synthesisofanewzincmixedligandcomplexandevaluationofitsantidiabeticpropertiesinhighfatdietlowdosestreptozotocininduceddiabeticrats
AT roshanadevivellai synthesisofanewzincmixedligandcomplexandevaluationofitsantidiabeticpropertiesinhighfatdietlowdosestreptozotocininduceddiabeticrats
AT iyyampillaisubramanian synthesisofanewzincmixedligandcomplexandevaluationofitsantidiabeticpropertiesinhighfatdietlowdosestreptozotocininduceddiabeticrats
AT sorimuthupillaisubramanian synthesisofanewzincmixedligandcomplexandevaluationofitsantidiabeticpropertiesinhighfatdietlowdosestreptozotocininduceddiabeticrats